Is BlackRock a Buy, Sell or Hold
With a large suite of ETF offerings as well as…
Sell
27
CRSP Quote, Financials, Valuation and Earnings
Last price:
$37.78
Seasonality move
:
21.79%
Day range:
$37.23 - $38.22
52-week range:
$30.04 - $67.88
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.68x
Volume:
1M
Avg. volume:
2.2M
1-year change:
-32.02%
Market cap:
$3.2B
Revenue:
$35M
EPS (TTM):
-$4.37
CRISPR Therapeutics AG SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
CRSP
CRISPR Therapeutics AG
|
11/06/2023 | 10-Q | 10-Q filing on 11/06/2023 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
08/07/2023 | 10-Q | 10-Q filing on 08/07/2023 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
05/08/2023 | 10-Q | 10-Q filing on 05/08/2023 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/01/2022 | 10-Q | 10-Q filing on 11/01/2022 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
08/08/2022 | 10-Q | 10-Q filing on 08/08/2022 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
05/09/2022 | 10-Q | 10-Q filing on 05/09/2022 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/03/2021 | 10-Q | 10-Q filing on 11/03/2021 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
07/29/2021 | 10-Q | 10-Q filing on 07/29/2021 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
04/27/2021 | 10-Q | 10-Q filing on 04/27/2021 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
02/16/2021 | 10-K | 10-K filing on 02/16/2021 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
10/28/2020 | 10-Q | 10-Q filing on 10/28/2020 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
07/27/2020 | 10-Q | 10-Q filing on 07/27/2020 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
04/28/2020 | 10-Q | 10-Q filing on 04/28/2020 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
02/12/2020 | 10-K | 10-K filing on 02/12/2020 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
10/28/2019 | 10-Q | 10-Q filing on 10/28/2019 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
07/29/2019 | 10-Q | 10-Q filing on 07/29/2019 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
04/29/2019 | 10-Q | 10-Q filing on 04/29/2019 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
02/25/2019 | 10-K | 10-K filing on 02/25/2019 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/07/2018 | 10-Q | 10-Q filing on 11/07/2018 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
08/07/2018 | 10-Q | 10-Q filing on 08/07/2018 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
05/08/2018 | 10-Q | 10-Q filing on 05/08/2018 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
03/08/2018 | 10-K | 10-K filing on 03/08/2018 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/08/2017 | 10-Q | 10-Q filing on 11/08/2017 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
08/10/2017 | 10-Q | 10-Q filing on 08/10/2017 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
05/11/2017 | 10-Q | 10-Q filing on 05/11/2017 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
03/10/2017 | 10-K | 10-K filing on 03/10/2017 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/22/2016 | 10-Q | 10-Q filing on 11/22/2016 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Uber Stock a Buy, Sell or Hold?
Uber (NYSE:UBER) has been through quite a ride over the…
Is Micron a Good Stock to Buy Now?
Like most of its peers in the semiconductor industry, Micron…
Stock Ideas
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 32x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 31x
Sell
46
Is NVDA Stock a Buy?
Market Cap: $2.5T
P/E Ratio: 35x
Alerts
Sell
23
UNH alert for Apr 18
UnitedHealth Group [UNH] is down 22.4% over the past day.
Sell
32
MAN alert for Apr 18
ManpowerGroup [MAN] is down 19.07% over the past day.
Sell
24
GPN alert for Apr 18
Global Payments [GPN] is down 17.44% over the past day.
